158 results on '"Pafili, Kalliopi"'
Search Results
2. Metabolic surgery-induced changes of the growth hormone system relate to improved adipose tissue function
3. Skin advanced glycation end products as a screening tool of neuropathy in type 2 diabetes mellitus
4. Mitochondrial respiration is decreased in visceral but not subcutaneous adipose tissue in obese individuals with fatty liver disease
5. Novel molecular markers of cardiovascular disease risk in type 2 diabetes mellitus
6. Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans
7. List of contributors
8. Treatment of diabetic peripheral neuropathy: technologies, exercise, and alternative treatments
9. Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis
10. Metabolic liver disease in diabetes – From mechanisms to clinical trials
11. Skin AGEs and diabetic neuropathy
12. Clinical Tools for Peripheral Neuropathy to Exclude Cardiovascular Autonomic Neuropathy in Type 2 Diabetes Mellitus
13. The Diagnostic Utility of VibraTip for Distal Symmetrical Polyneuropathy in Type 2 Diabetes Mellitus
14. The sugar-free paradox: cardiometabolic consequences of erythritol
15. Integrating Medical Scientific Knowledge with the Semantically Quantified Self
16. Abdominal aortic aneurysms and diabetes mellitus
17. Mean platelet volume and coronary artery disease
18. New antihyperglycaemic agents and cardiovascular disease: letʼs be optimistic
19. Letter to the Editor Regarding: Diabetic Peripheral Neuropathy as a Predictor of Asymptomatic Myocardial Ischemia in Type 2 Diabetes Mellitus: A Cross-Sectional Study
20. 1412-P: Preexisting Nonalcoholic Steatohepatitis Attenuates Improvement of Adipose Tissue OXPHOS Capacity after Weight-Loss Surgery
21. Correlation Between Skin Advanced Glycation End Products and Cardiac Autonomic Neuropathy Among Subjects with Type 2 Diabetes Mellitus
22. Chapter 17 - Treatment of diabetic peripheral neuropathy: technologies, exercise, and alternative treatments
23. Experimental and Emerging Free Fatty Acid Receptor Agonists for the Treatment of Type 2 Diabetes
24. Skin Advanced Glycation End Products among Subjects with Type 2 Diabetes Mellitus with or without Distal Sensorimotor Polyneuropathy
25. 1212-P: Adipose Tissue Mitochondrial Function in Humans with Varying Liver Histology
26. Considerations for single- versus multiple-drug pharmacotherapy in the management of painful diabetic neuropathy
27. Current Pharmacological Treatment of Painful Diabetic Neuropathy: A Narrative Review
28. Risk Phenotypes of Diabetes and Association with COVID-19 Severity and Death – A Living Systematic Review and Meta-Analysis
29. Cardiovascular Autonomic Neuropathy and Distal Symmetric Sensorimotor Polyneuropathy: These Two Diabetic Microvascular Complications do not Invariably Co-Exist
30. The Diagnostic Utility of VibraTip for Distal Symmetrical Polyneuropathy in Type 2 Diabetes Mellitus
31. Erhöhte Laktat-Elimination als metabolisches Merkmal der hepatoprotektiven HSD17B13-Spleißvariante rs72613567:TA.
32. Automated Measurement of Sural Nerve Conduction is a Useful Screening Tool for Peripheral Neuropathy in Type 1 Diabetes Mellitus
33. Advances in pharmacological treatment of type 1 diabetes during pregnancy
34. Pharmacotherapy for gestational diabetes mellitus: still insulin, or what about sulfonylureas?
35. Exercise to improve diabetic peripheral neuropathy: An additional option?
36. Pharmacotherapy for gestational diabetes
37. Metabolic disorders during pregnancy and postpartum cardiometabolic risk
38. Neuropathy in Diabetes: “One Cannot Begin It Too Soon”
39. Ipragliflozin and sodium glucose transporter 2 inhibitors to reduce liver fat: will the prize we sought be won?
40. Dapagliflozin for the treatment of type 1 diabetes mellitus
41. Cardiovascular Autonomic Neuropathy and Distal Symmetric Sensorimotor Polyneuropathy: These Two Diabetic Microvascular Complications do not Invariably Co-Exist
42. Pharmacokinetic and pharmacodynamic drug evaluation of tofogliflozin for the treatment of type 2 diabetes
43. Evaluation of sural nerve automated nerve conduction study in the diagnosis of peripheral neuropathy in patients with type 2 diabetes mellitus
44. The relationship between obstructive sleep apnoea and coronary heart disease
45. Luseogliflozin and other sodium-glucose cotransporter 2 inhibitors: no enemy but time?
46. Simplified Diagnosis of Cardiovascular Autonomic Neuropathy in Type 2 Diabetes Using Ewing's Battery
47. Thermography in the follow up of the diabetic foot: best to weigh the enemy more mighty than he seems
48. Gevokizumab in type 1 diabetes mellitus: extreme remedies for extreme diseases?
49. Tofogliflozin: the road goes ever on
50. The importance of patient compliance with insulin pens: how can a new user-friendly pen help?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.